Expiratory variability index is associated with asthma risk, wheeze and lung function in infants with recurrent respiratory symptoms

Ville‐Pekka Seppä, Javier Gracia‐Tabuenca, Anne Kotaniemi‐Syrjänen, Kristiina Malmström, Anton Hult, Anna S. Pelkonen, Mika J. Mäkelä, Jari Viik, L. Pekka Malmberg

TL;DR

This paper introduces the Expiratory Variability Index (EVI), a novel metric derived from overnight impedance pneumography, to assess lung function in infants. They found that reduced EVI is linked to higher asthma risk, poorer lung function, and specific respiratory symptoms in infants, suggesting EVI as a promising, non-invasive tool for early detection and monitoring of respiratory issues in this challenging age group.

What Problem Does This Paper Address?

Assessing lung function in infants is notoriously difficult due to their inability to perform standard pulmonary tests. This lack of objective, routine-use tools hinders early diagnosis and management of respiratory conditions like asthma. While impedance pneumography (IP) has shown promise for monitoring breathing patterns, its utility in quantifying subtle changes related to airway obstruction and asthma risk in infants has remained largely unexplored. Specifically, the paper addresses the gap in understanding whether overnight tidal breathing variability, a potential indicator of airway issues, can be reliably measured and correlated with asthma risk and lung function in infants with recurrent respiratory symptoms.

Methods

The core of this study revolves around the Expiratory Variability Index (EVI). EVI is calculated by analyzing correlations between multiple overnight tidal breathing flow-volume (TBFV) curves obtained via impedance pneumography (IP). Specifically, it quantifies the dissimilarity between these curves, with lower EVI values indicating less variability. The IP device used was a prototype for home overnight recordings.

For lung function assessment, maximal flow at functional residual capacity (VmaxFRC) was measured using rapid thoracic compression under sedation. Fractional exhaled nitric oxide (FeNO) was also measured. The study employed statistical methods including Student's t-tests, ANOVA linear trend tests, and Mann-Whitney U tests to compare EVI across different asthma risk groups and symptom categories. Pearson correlations were used to assess the association of EVI with continuous variables like VmaxFRC and FeNO.

Datasets

The study utilized data from 36 infants with recurrent respiratory symptoms, recruited between January 2014 and May 2017 from the Department of Allergy at Helsinki University Hospital. These infants had a mean age of 12.8 months (range 6-23 months). The dataset included information on asthma risk classification (high, intermediate, low), main symptoms (prolonged expiration/wheeze vs. cough), lung function (VmaxFRC), and in a subgroup, airway hyperresponsiveness (AHR) to methacholine. No new benchmark datasets were introduced; rather, existing patient data was analyzed.

Key Insights and Ideas

  • EVI as a sensitive marker: The study highlights EVI as a potentially sensitive, non-invasive marker for detecting subtle airway obstruction and its association with asthma risk in infants.
  • Overnight IP is feasible: The successful implementation of overnight IP recordings at home demonstrates the feasibility of this technique for routine monitoring in infants.
  • Distinguishing symptom types: EVI appears to differentiate between infants with wheeze/prolonged expiration and those with only cough, suggesting it might be more specific to lower airway issues.
  • EVI and lung function link: The positive correlation between EVI and VmaxFRC suggests that improved lung function is associated with more variable breathing patterns, which is counterintuitive but could reflect better adaptive mechanisms.

Key Results

  • Asthma Risk: EVI was significantly different across asthma risk categories, with lower EVI observed in children with high asthma risk (ANOVA linear trend test, p=0.022).
  • Symptoms: Infants with prolonged expiration or wheeze as their main symptom had lower EVI compared to those with only cough (Student's t-test, p=0.044).
  • Lung Function: EVI showed a positive correlation with VmaxFRC (Pearson correlation, r=0.52, p=0.002), indicating that higher lung function was associated with higher EVI.
  • Nasal Congestion: EVI was not statistically different between infants with and without nasal congestion (Mann-Whitney U test, p=0.50).
  • Other Associations: EVI was not significantly associated with AHR, atopic eczema, or prick test results.

Limitations and Future Work

The authors acknowledge several limitations:

  • Lack of a healthy control group: This prevents the estimation of the proportion of abnormal EVI results in different patient groups or the assessment of EVI's specificity for asthma risk.
  • No longitudinal data: The study is cross-sectional, limiting the ability to assess the progression of respiratory issues or the predictive value of EVI over time.
  • Modest associations: The associations found were modest, which the authors attribute to the small sample size and the heterogeneity of asthma outcomes.
  • Interactions with sleep architecture: The study did not investigate how sleep stages might influence EVI, suggesting this as a direction for future research.

Future work should focus on replicating these findings in larger cohorts to confirm EVI's utility and explore its predictive capabilities for respiratory symptoms and asthma in infants. Further research into the interplay between sleep architecture and EVI is also warranted.

Summary updated

Abstract

<b>Impedance pneumography enables the measurement of the expiratory variability index (EVI) at home during a night9s sleep in infants with recurrent respiratory symptoms. EVI is associated with asthma risk, symptoms and lung function.</b>https://bit.ly/2PF2cx8
BibTeX
@inproceedings{seppa2020expiratory,
  author = {Ville‐Pekka Seppä and Javier Gracia‐Tabuenca and Anne Kotaniemi‐Syrjänen and Kristiina Malmström and Anton Hult and Anna S. Pelkonen and Mika J. Mäkelä and Jari Viik and L. Pekka Malmberg},
  title = {{Expiratory variability index is associated with asthma risk, wheeze and lung function in infants with recurrent respiratory symptoms}},
  booktitle = {ERJ Open Research},
  year = {2020},
  doi = {10.1183/23120541.00167-2020},
}

Loading related content...

Figure